Articles tagged with Pandemic Influenza
A study predicts that using Tamiflu prophylactically could reduce illness and death rates during an influenza pandemic by half, with a cost savings of $70,000 per 1,000 population. Prophylaxis with antivirals or vaccines is considered a crucial strategy in the early months of a pandemic.
A study by researchers at the University of Iowa found that veterinarians with occupational exposure to birds have significantly higher levels of antibodies against avian influenza viruses. The greatest risk factor for infection was examining sick birds, highlighting the need for priority access to pandemic vaccines and antivirals.
Researchers used human antibodies derived from immune cells of H5N1 survivors to treat and protect mice from the virus. The study found that these antibodies could neutralize the virus and prevent death in mice, offering a promising therapeutic approach for pandemic influenza.
Researchers surveyed healthcare workers about their willingness to report to work during disasters. Workers were more likely to come to work when they felt their role was important, safe traveling to work, and supported by family. However, fear and uncertainty can lead to a decrease in staff availability, complicating disaster response.
Experts argue that researchers should focus broadly on influenza viruses, improving knowledge of basic biological means, enhancing surveillance, and developing new antivirals and diagnostics. This approach can also help combat seasonal influenza, a major public health concern in the US.
Research shows that influenza epidemics are associated with a rise in deaths from heart disease and flu can trigger heart attacks. The study highlights the importance of increasing vaccination rates in people at risk of coronary heart disease.
A new experimental flu vaccine made in insect cells has been shown to be safe and effective in protecting against the flu, with a stronger immune response at higher doses. The use of cell culture systems to grow vaccines is a growing business and could potentially slice off months from the production process.
The RAND Corporation's expert panel identifies key components of public health emergency preparedness, including a coordinated rapid-response capability, adequate public health worker and volunteer numbers, and regular testing. The report emphasizes the importance of community engagement and clear definitions to ensure readiness.
The NIAID is awarding $23 million per year for seven years to establish six Centers of Excellence for Influenza Research and Surveillance. These centers will bolster influenza research in key areas, including understanding how the virus causes disease and how the human immune system responds to infection with the virus.
UC Davis has been named a partner in a new $18.5 million national research center to study influenza viruses with pandemic potential. The Center for Rapid Influenza Surveillance and Research will expand the federal government's early-detection program for influenza and help reduce the chances of deadly outbreaks.
The University of Rochester Medical Center has been awarded a $26 million contract to establish the New York Influenza Center of Excellence, one of six nationwide centers focused on improving flu research. The center aims to develop more effective vaccines against seasonal influenza and future pandemics.
Historical analyses of the 1918 Spanish influenza pandemic reveal that cities with early public health measures had lower peak weekly death rates and overall mortality compared to those that waited. Implementing multiple social containment measures within a few days of first local cases recorded cut peak death rates by up to half.
The University of Alaska Fairbanks will collect and test over 8,000 samples from Alaska and Russia to understand the genetic changes of flu viruses and their success in animal hosts. The research aims to develop new knowledge on the ecology of the influenza virus and its impact on bird populations.
The University of Minnesota will receive funding to monitor domestic and international wild bird populations for avian influenza viruses, aiming to rapidly identify pandemic threats. The center's research will support public health strategies for controlling the impact of an influenza pandemic.
A review of 1918 pandemic flu studies reveals more unanswered questions than answers, particularly regarding the origins and impact on young adults. Further study is crucial for pandemic planning and preparedness efforts.
Developing an H5 vaccine faces hurdles in current egg production methods and the molecule's ability to stimulate an immune reaction, requiring two shots for full immunization. The ideal adjuvant must still be found to boost vaccine effectiveness.
Developing countries face a critical shortage of pandemic influenza vaccines, with only 500 million doses available globally. The WHO is urging international agreement to ensure affordable vaccine access for these nations, demonstrating global solidarity in the face of the next pandemic threat.
Researchers found that modifying the 1918 flu virus's hemagglutinin receptor binding site reduced its ability to transmit in ferrets. The study suggests that understanding this molecular mechanism could lead to the development of novel drugs to stop influenza transmission and prevent epidemics.
A mathematical model predicts that international cooperation on sharing antiviral drugs is key to slowing down the spread of a bird flu pandemic. The 'reproductive number' of the virus plays a critical role in determining its potential for global spread.
Researchers predict 62 million deaths in a year if similar pandemic occurs, with 96% of fatalities in developing nations. The study's findings suggest that wealth disparity plays a significant role in disease burden, with higher-income individuals less likely to die.
A recent study estimates that a similar flu pandemic to the 1918-1920 pandemic could claim 62 million lives worldwide. The majority of deaths would occur in developing countries, where per capita income is lower.
Developed using best evidence and expert panels, a triage protocol prioritizes access to ventilators and antiviral medications in patients with severe symptoms. The protocol aims to ensure fair distribution of limited resources during an overwhelmed healthcare system.
A powerful analysis reveals that only one-third of high-risk populations in Europe receive seasonal influenza vaccine, resulting in avoidable morbidity and mortality. Implementing EU vaccination recommendations could reduce the number of cases of death and illness from influenza, as well as contribute to flu pandemic preparedness.
Researchers have identified key genetic changes required for the H5N1 avian influenza virus to adapt to easily recognize human receptors. The study provides a molecular blueprint for these changes, which could help detect pandemic strains earlier and prepare public health officials and vaccine manufacturers.
The U.S. Vaccine and Infectious Disease Organization has discovered a crucial pathway that supports the influenza A virus's ability to reproduce itself. This finding could lead to the development of new live vaccines and antiviral drugs for influenza epidemics and pandemics.
Researchers are urging more study on non-pharmaceutical interventions such as social distancing and hand washing during annual flu season. The lack of comprehensive data on community epidemiologic data hinders the design of effective interventions, making it crucial to prepare for potential pandemic flu.
A large majority of Americans are willing to make significant changes in their lives and cooperate with public health officials' recommendations during a pandemic flu outbreak. However, many would face critical work-related problems and financial concerns if they had to stay home from work for an extended period.
Scientists have developed a vaccine that protects mice against the 1918 influenza virus, which killed 50 million people worldwide. The vaccine works by stimulating antibodies capable of neutralizing the virus, providing a potential solution to future pandemic flu strains.
A study by ANU researchers highlights the vital role of GPs in containing pandemics, but notes regulatory and funding hurdles. The team's findings emphasize the need for collaborative practices to prepare for influenza outbreaks.
A study reviewing 45 national pandemic influenza plans found that countries have not consistently prioritized who should receive vaccines, antivirals, ventilators, face masks, and other critical resources. Healthcare workers are often prioritized, but with varying criteria among countries.
A new study found that 30% of nations have not prioritized either vaccine nor drugs, while 49% prioritize antiviral drugs and 62% prioritize flu vaccines. The allocation decisions vary across countries, with healthcare workers consistently ranked top, but a wide variation in choosing next in line.
Researchers found that a prime-boost strategy using different subtypes of H5N1 vaccines significantly boosted immune responses in individuals with prior exposure. Additionally, an intradermal approach to delivering the vaccine showed promise but did not improve the immune response. These findings suggest pre-pandemic priming with exist...
The Journal of Infectious Diseases has published a supplement offering current information on pandemic and seasonal influenza, featuring leading experts discussing research and recommendations. The article highlights key findings on disease surveillance, vaccine manufacturing, and public health response plans.
International experts issue checklists to address the interests of the world's most disadvantaged during a pandemic. The Bellagio Statement of Principles aims to improve public health planning and response with the needs of poor groups in mind.
A comprehensive mouse study provides new clues about the virulence of the 1918 influenza virus. The research found that a hyperactive immune response triggered by the virus may contribute to its exceptional lethality. Understanding this phenomenon is crucial for developing therapies against future flu pandemics.
A new study by UW researchers suggests that the 1918 flu pandemic was deadly due to a severe immune system response, contradicting the conventional wisdom of secondary infections. The study found activated genes related to immune responses and programmed cell death, indicating an overzealous host immune system.
A clinical trial has demonstrated the efficacy of an H9N2 avian flu vaccine combined with an adjuvant in generating a strong antibody response in humans. The results suggest that even low doses of the vaccine can provide protection, making it a promising tool in pandemic prevention.
Prisons in the US are woefully ill-prepared for a flu pandemic, putting the public at risk. Nearly 85% of prisoners will be released within a year, carrying diseases like HIV and tuberculosis with them.
Researchers propose using existing facilities to produce vaccines from cell cultures, which could make enough doses to cover the US in just 3-4 months. This approach would reduce downtime and capital investments required for new dedicated facilities.
Researchers have developed a live, attenuated H5N1 avian flu vaccine that protected mice and ferrets from deadly infection with naturally occurring H5N1 flu viruses. The vaccine demonstrated cross-protection against different emerging H5N1 virus strains.
Research found that air travel affects both the peak date and rate of spread of flu in the US. The study analyzed government records on deaths from flu and pneumonia between 1996 and 2005 and discovered that flu season started about two weeks later than usual after 9/11 restrictions on air travel were implemented.
A recent analysis suggests that limiting flights after 9/11 delayed the onset of the 2001-2002 U.S. flu season and slowed flu spread. By analyzing real data on influenza mortality and air travel volume, researchers found a strong correlation between reduced airline activity and delayed flu peaks.
A new H5N1 influenza vaccine has produced a safe and effective immune response in healthy people at low doses, with the highest dose showing the best response. The vaccine was well-tolerated and did not have significantly more side effects compared to a placebo.
Researchers found that transfusions with blood products from recovered Spanish flu patients may reduce mortality and improve symptoms for hospitalized patients. The study suggests similar transfusions could be useful in treating victims of a bird flu pandemic, especially given the problems with existing vaccines and treatments.
A groundbreaking study finds that in utero health has a stronger impact on adult economic outcomes than inherited traits, with children of infected mothers facing lower graduation rates and earnings. The study's findings suggest targeting early-life health could help reduce racial disparities in socioeconomic status.
A mathematical model predicts that voluntary household-based quarantine and isolation can substantially reduce the number of infected individuals and deaths from pandemic influenza. The study estimates a 27% reduction in symptomatic cases and a corresponding decrease in deaths, with potential benefits for cities worldwide.
Researchers suggest that cholesterol-lowering drugs like statins could be useful in treating and preventing severe complications of the flu during a pandemic. Statins have anti-inflammatory and immunomodulatory effects that may also benefit people with influenza, making them a potential alternative to vaccines.
A new experimental vaccine has shown significant protective effects against multiple H5N1 strains in lab animals. The two-dose vaccination schedule induced higher levels of antibodies that were cross-reactive to various viruses, suggesting a potential solution for stockpiling vaccines during pandemics.
The International Society for Influenza and other Respiratory Diseases has launched a new journal, Influenza and Other Respiratory Viruses, with renowned influenza expert Alan Hampson at the helm. The journal aims to bring together international knowledge and expertise in combating the global threat of an influenza pandemic.
Researchers argue for alternative approach to vaccine distribution, considering individual's degree of life investment and life expectancy. Healthy people from early adolescence to middle age are prioritized for vaccination, aiming to maximize years of life.
The DCPP identifies four major health challenges: cardiovascular diseases, HIV/AIDS, influenza, and malaria. The authors recommend adopting cost-effective interventions on a wider scale to tackle these threats.
Five Spanish hospitals are participating in a phase III trial for an H5N1 influenza pandemic vaccine, alongside countries such as Germany, Holland, and France. The vaccine uses fractionated viral proteins and an adjuvant to stimulate the immune system, with the goal of improving vaccine production strategies.
The H5N1 virus poses a significant threat, prompting researchers to revisit studies of influenza A viruses. The immune system response to H5N1 can be catastrophic, with a 'cytokine storm' causing rapid death. Understanding the battle between the immune system and influenza A viruses holds promise for better therapies and vaccines.
The Asia-Pacific region is facing challenges in pandemic preparedness, with some countries lacking comprehensive operational guidance manuals. However, countries like Hong Kong, Australia, and New Zealand have developed robust plans to respond to pandemic influenza, drawing from their experience with SARS.
Researchers used mathematical modeling to simulate worldwide outbreaks and concluded that restrictions on air travel would achieve very little in controlling the spread of a new flu virus. Local measures such as vaccines and antiviral drugs could be more effective in controlling the spread of the virus.
A combination of interventions could be highly effective at reducing transmission in a flu pandemic, potentially saving many lives. School closure combined with antiviral drugs can halve the number of people getting ill.
A recent study by London School of Hygiene & Tropical Medicine found considerable gaps in pandemic preparedness across Europe. The report analyzed national plans and concluded that increased cooperation is needed to ensure effective response to a pandemic.
A study evaluated European countries' preparedness plans against WHO's checklist, finding that surveillance planning was good but maintenance of essential services, putting plans into practice, and public-health interventions were less well prepared. The implementation of these interventions was unclear in many plans.
A study found that clinical staff, such as physicians and nurses, were more likely to report for work than technical or support staff. The willingness to report was strongest among employees who perceived an importance in their work during a pandemic, while technical workers felt they had little role to play.
A survey of healthcare staff in the US found that over 40% would be unlikely to report to work during a flu pandemic, while 66% feared putting themselves at risk. The study also showed that many felt the need for additional training to prepare for such an event.